Clinical Trial Update: Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) [Phase 3]

View source ↗

Summary

Phase III randomized trial in multiple myeloma comparing thalidomide/dexamethasone vs vincristine/adriamycin/dexamethasone was terminated with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (Adriamycin) (doxorubicin)
• Thalidomide (thalidomide)
• Vincristine (vincristine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2014-03-04